Related Experiment Video
Updated: Jun 16, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Towards non-thrombogenic performance of blood recirculating devices
D Bluestein1, K B Chandran, K B Manning
1Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794, USA. danny.bluestein@sunysb.edu
New research reviews methodologies to optimize blood recirculating devices, focusing on flow-induced stresses that activate platelets. Understanding these interactions is key to reducing thromboembolism and improving cardiovascular device safety.
Area of Science:
- Biomedical Engineering
- Cardiovascular Science
- Medical Device Development
Background:
- Implantable blood recirculating devices are vital for severe cardiovascular diseases.
- Hemolysis and thromboembolism are significant challenges limiting device efficacy.
- Optimizing thrombogenic performance is crucial for device safety and patient outcomes.
Purpose of the Study:
- To review methodologies for optimizing the thrombogenic performance of blood recirculating devices.
- To explore the interaction between flow-induced stresses and blood constituents.
- To support the hypothesis that non-physiological flow patterns initiate thromboembolism.
Main Methods:
- Review of existing research on blood-device interactions.
- Analysis of flow-induced stresses and their effect on blood platelets.
- Utilizing advanced numerical and experimental tools to study thromboembolic mechanisms.
Main Results:
- Flow-induced stresses and non-physiological patterns are primary drivers of thromboembolism.
- Platelet activation and aggregation are significantly influenced by blood flow dynamics.
- Elucidation of mechanisms leading to thromboembolism in prosthetic devices.
Conclusions:
- Understanding flow-device interactions is critical for reducing thromboembolic events.
- Future research should focus on mitigating non-physiological flow patterns.
- Optimized devices hold promise for effective destination therapy in cardiovascular care.
More Related Videos
09:41Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
11:49Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care